Smith & Nephew plc (ETR:NPW1)

Market Cap	13.28B +22.4%
Revenue (ttm)	5.07B +5.4%
Net Income	419.07M +61.0%
EPS	0.48 +59.9%
Shares Out	n/a
PE Ratio	31.68
Forward PE	16.77
Dividend	0.13 (0.83%)
Ex-Dividend Date	Oct 2, 2025

Volume	n/a
Average Volume	235
Open	15.53
Previous Close	15.49
Day's Range	15.53 - 15.53
52-Week Range	13.66 - 16.57
Beta	n/a
RSI	67.59
Earnings Date	Mar 2, 2026

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1856
• Employees: 17,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: NPW1

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial numbers in USD